Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Fengbei Biotech Stock Co's quarterly market cap
increased
from Sep. 2025 (¥0 Mil) to Dec. 2025 (¥5,998 Mil) and
increased
from Dec. 2025 (¥5,998 Mil) to Mar. 2026 (¥7,158 Mil).
Suzhou Fengbei Biotech Stock Co's annual market cap
stayed the same
from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥0 Mil) but then
increased
from Dec. 2024 (¥0 Mil) to Dec. 2025 (¥5,998 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Suzhou Fengbei Biotech Stock Co's Enterprise Value for Today is ¥3,821 Mil.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Suzhou Fengbei Biotech Stock Co Market Cap Related Terms
Suzhou Fengbei Biotech Stock Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603334 vs WM, RSG, WCN: Market Cap Comparison
For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Fengbei Biotech Stock Co Market Cap vs Waste Management Industry
For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's Market Cap falls into.
Suzhou Fengbei Biotech Stock Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Market Cap of ¥4,562 Mil as of Jul. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #50 out of 249 companies in the Waste Management industry, placing it in the top 20.1%.
Is Suzhou Fengbei Biotech Stock Co's Market Cap too high?
Suzhou Fengbei Biotech Stock Co's current Market Cap is ¥4,562 Mil. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #50 out of 249 companies in the Waste Management industry, which is in the top quartile — a strong position relative to peers. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Market Cap compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #50 out of 249 companies for Market Cap. This places Suzhou Fengbei Biotech Stock Co in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 88.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Waste Management company?
The median Market Cap among Waste Management companies is 88.14, based on 249 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median Market Cap is 88.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current Market Cap is ¥4,562 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Market Cap of ¥4,562 Mil. The current Market Cap is ¥4,562 Mil. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Market Cap is ¥4,562 Mil as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Business Description
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score
Get the complete analysis for SHSE:603334
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
